215 related articles for article (PubMed ID: 37697332)
21. Nanodrugs Incorporating LDHA siRNA Inhibit M2-like Polarization of TAMs and Amplify Autophagy to Assist Oxaliplatin Chemotherapy against Colorectal Cancer.
Hu L; Huang S; Chen G; Li B; Li T; Lin M; Huang Y; Xiao Z; Shuai X; Su Z
ACS Appl Mater Interfaces; 2022 Jul; 14(28):31625-31633. PubMed ID: 35796429
[TBL] [Abstract][Full Text] [Related]
22. Thermosensitive methyl-cellulose-based injectable hydrogel carrying oxaliplatin for the treatment of peritoneal metastasis in colorectal cancer.
Yang J; Wei Y; Gao L; Li Z; Yang X
J Mater Chem B; 2024 May; 12(21):5171-5180. PubMed ID: 38687592
[TBL] [Abstract][Full Text] [Related]
23. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
[TBL] [Abstract][Full Text] [Related]
24. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract][Full Text] [Related]
25. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
26. [Study on inhibitory effect of combined administration of bear bile powder and cyclophosphamide on colorectal cancer liver metastasis by regulating tumor microenvironment].
Cui W; Liu S; Yang M; Zhang T; Cai L; Qiu SL; Zheng J; Miao YJ; Zhao LM; Du J
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):1036-40. PubMed ID: 23847953
[TBL] [Abstract][Full Text] [Related]
27. Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe
Li X; Cheng Y; Yang Z; Ji Q; Huan M; Ye W; Liu M; Zhang B; Liu D; Zhou S
J Nanobiotechnology; 2024 Mar; 22(1):93. PubMed ID: 38443927
[TBL] [Abstract][Full Text] [Related]
28. Fatty change of the liver microenvironment influences the metastatic potential of colorectal cancer.
Masaki S; Hashimoto Y; Kunisho S; Kimoto A; Kitadai Y
Int J Exp Pathol; 2020 Oct; 101(5):162-170. PubMed ID: 32783302
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer.
Zeng D; Wang M; Wu J; Lin S; Ye Z; Zhou R; Wang G; Wu J; Sun H; Bin J; Liao Y; Li N; Shi M; Liao W
Front Oncol; 2021; 11():620688. PubMed ID: 33833986
[No Abstract] [Full Text] [Related]
30. Oridonin Enhances the Anti-Metastasis Effect of Oxaliplatinliplatin on Colorectal Cancer Liver Metastasis.
Wen D; Yang YS; Gao DZ; Wang Z; Jiang QW; Zhao XF
Bull Exp Biol Med; 2021 Nov; 172(1):26-32. PubMed ID: 34792718
[TBL] [Abstract][Full Text] [Related]
31. Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
Oshiro H; Tome Y; Kiyuna T; Yoon SN; Lwin TM; Han Q; Tan Y; Miyake K; Higuchi T; Sugisawa N; Katsuya Y; Park JH; Zang Z; Razmjooei S; Bouvet M; Clary B; Singh SR; Kanaya F; Nishida K; Hoffman RM
Anticancer Res; 2019 Sep; 39(9):4667-4671. PubMed ID: 31519565
[TBL] [Abstract][Full Text] [Related]
32. Oxaliplatin-/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer.
Shen F; Feng L; Zhu Y; Tao D; Xu J; Peng R; Liu Z
Biomaterials; 2020 Oct; 255():120190. PubMed ID: 32563943
[TBL] [Abstract][Full Text] [Related]
33. An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer.
Wang Q; Wang Z; Wu Y; Klinke DJ
BMC Cancer; 2020 Jan; 20(1):26. PubMed ID: 31914948
[TBL] [Abstract][Full Text] [Related]
34. Chemoimmunotherapy by combining oxaliplatin with immune checkpoint blockades reduced tumor burden in colorectal cancer animal model.
Wang W; Wu L; Zhang J; Wu H; Han E; Guo Q
Biochem Biophys Res Commun; 2017 May; 487(1):1-7. PubMed ID: 28042031
[TBL] [Abstract][Full Text] [Related]
35. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
Zhang J; Li C; Sun L; Sun D; Zhao T
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068
[TBL] [Abstract][Full Text] [Related]
36. Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells.
Wang M; Xiang Y; Wang R; Zhang L; Zhang H; Chen H; Luan X; Chen L
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431875
[TBL] [Abstract][Full Text] [Related]
37. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
38. [Synergistic effect of polysaccharide from
Li P; Yuan P; Que Y; Liu X; Wang G
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):504-513. PubMed ID: 33963708
[TBL] [Abstract][Full Text] [Related]
39. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
40. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
